XML 33 R23.htm IDEA: XBRL DOCUMENT v3.23.1
Restatement of Condensed Consolidated Financial Statements (Tables)
3 Months Ended
Dec. 31, 2022
Restatement of Condensed Consolidated Financial Statements  
Impact of the financial statement adjustments on the Company's previously reported Condensed Consolidated Financial Statements

The following tables present the impact of the financial statement adjustments on the Company’s previously reported Condensed Consolidated Statements of Income for the three months ended December 31, 2022 and January 1, 2022.

    

Three Months Ended

Three Months Ended

December 31, 2022

January 1, 2022

(Unaudited)

(Unaudited)

Previously

Investigation

Other

Previously

Investigation

Other

    

Reported

    

Adjustments

    

Adjustments

    

As Restated

    

Reported

    

Adjustments

    

Adjustments

    

As Restated

 

(In thousands, except per share data)

Net sales

$

2,361,361

$

(5,553)

$

$

2,355,808

$

1,757,325

$

(999)

$

$

1,756,326

Cost of sales

2,170,654

(10,232)

2,160,422

1,612,836

2,193

1,615,029

Gross profit

190,707

4,679

195,386

144,489

(3,192)

141,297

Operating expenses:

Selling, general and administrative

60,730

60,730

61,475

61,475

Research and development

5,599

5,599

4,777

4,777

Restructuring and other

631

631

1,414

1,414

Gain on sale of long-lived assets

(4,610)

(4,610)

Total operating expenses

66,960

66,960

63,056

63,056

Operating income

123,747

4,679

128,426

81,433

(3,192)

78,241

Interest income

2,933

2,933

309

309

Interest expense

(8,681)

(8,681)

(4,877)

(4,877)

Other income (expense), net

(6,712)

(6,712)

2,072

2,072

Interest and other, net

(12,460)

(12,460)

(2,496)

(2,496)

Income before income taxes

111,287

4,679

115,966

78,937

(3,192)

75,745

Provision for income taxes

19,788

1,064

20,852

20,303

(735)

19,568

Net income before noncontrolling interest

91,499

3,615

95,114

58,634

(2,457)

56,177

Less: Net income due to noncontrolling interest

3,100

3,100

Net income due to common shareholders

$

88,399

$

3,615

$

$

92,014

$

58,634

$

(2,457)

$

$

56,177

Net income due to common shareholders per share:

Basic

$

1.53

$

0.06

$

$

1.59

$

0.91

$

(0.04)

$

$

0.87

Diluted

$

1.48

$

0.06

$

$

1.54

$

0.89

$

(0.04)

$

$

0.85

Weighted average shares used in computing per share amounts:

Basic

57,727

57,727

64,399

64,399

Diluted

59,867

59,867

66,233

66,233

The following tables present the impact of the financial statement adjustments on the Company’s previously reported Condensed Consolidated Balance Sheets as of December 31, 2022 and October 1, 2022.

    

As of

As of

December 31, 2022

October 1, 2022

(Unaudited)

(Unaudited)

Previously

Investigation

Other

Previously

Investigation

Other

    

Reported

    

Adjustments

    

Adjustments

    

As Restated

    

Reported

    

Adjustments

    

Adjustments

    

As Restated

 

(In thousands)

ASSETS

Current assets:

 

  

  

 

  

 

  

 

  

 

  

Cash and cash equivalents

$

735,314

$

$

$

735,314

$

529,857

$

$

$

529,857

Accounts receivable, net of allowances

1,308,651

 

1,308,651

1,138,894

1,138,894

Contract assets

501,893

(17,423)

 

484,470

503,674

(27,953)

475,721

Inventories

1,728,000

(27,612)

 

1,700,388

1,691,081

(21,705)

14,723

1,684,099

Prepaid expenses and other current assets

80,675

 

80,675

62,044

62,044

Total current assets

4,354,533

(45,035)

 

4,309,498

3,925,550

(49,658)

14,723

3,890,615

Property, plant and equipment, net

591,155

 

591,155

575,170

575,170

Deferred tax assets

189,638

9,983

 

199,621

198,588

10,966

209,554

Other

171,886

 

171,886

160,192

160,192

Total assets

$

5,307,212

$

(35,052)

$

$

5,272,160

$

4,859,500

$

(38,692)

$

14,723

$

4,835,531

LIABILITIES AND STOCKHOLDERS’ EQUITY

 

  

Current liabilities:

 

  

Accounts payable

$

2,139,445

$

$

$

2,139,445

$

2,029,534

$

$

11,900

$

2,041,434

Accrued liabilities

292,212

1,466

 

1,600

295,278

275,735

1,441

4,423

281,599

Accrued payroll and related benefits

135,880

 

135,880

130,892

130,892

Short-term debt, including current portion of long-term debt

17,500

 

17,500

17,500

17,500

Total current liabilities

2,585,037

1,466

 

1,600

2,588,103

2,453,661

1,441

16,323

2,471,425

Long-term liabilities:

 

  

Long-term debt

325,007

 

325,007

329,237

329,237

Other

223,376

 

223,376

215,333

215,333

Total long-term liabilities

548,383

 

548,383

544,570

544,570

Contingencies (Note 8)

 

  

Stockholders’ equity

2,173,792

(36,518)

 

(1,600)

2,135,674

1,861,269

(40,133)

(1,600)

1,819,536

Total liabilities and stockholders’ equity

$

5,307,212

$

(35,052)

$

$

5,272,160

$

4,859,500

$

(38,692)

$

14,723

$

4,835,531

The following table presents the impact of the financial statement adjustments on the Company’s previously reported Condensed Consolidated Statements of Cash Flows for the three month period ended December 31, 2022 and January 1, 2022. There were no adjustments to cash flows provided by (used in) investing or financing activities for the three month period ended December 31, 2022 and January 1, 2022.

    

Three Months Ended

Three Months Ended

December 31, 2022

January 1, 2022

(Unaudited)

(Unaudited)

Previously

Investigation

Other

Previously

Investigation

Other

    

 Reported

    

Adjustments

    

Adjustments

    

As Restated

    

 Reported

    

Adjustments

    

Adjustments

    

As Restated

 

(In thousands)

CASH FLOWS PROVIDED BY (USED IN) OPERATING ACTIVITIES:

Net income before noncontrolling interest

$

91,499

 

$

3,615

 

$

 

$

95,114

$

58,634

 

$

(2,457)

 

$

 

$

56,177

Adjustments to reconcile net income before noncontrolling interest to cash provided by (used in) operating activities:

 

 

 

 

 

 

Depreciation and amortization

28,536

 

 

 

28,536

27,465

 

 

 

27,465

Stock-based compensation expense

11,609

 

 

 

11,609

9,032

 

 

 

9,032

Deferred income taxes

8,445

 

983

 

 

9,428

6,707

 

(648)

 

 

6,059

Other, net

(311)

 

 

 

(311)

(3,638)

 

 

 

(3,638)

Changes in operating assets and liabilities, net of amounts acquired:

 

 

 

 

 

 

Accounts receivable

(166,333)

 

 

 

(166,333)

(106,972)

 

 

316

 

(106,656)

Contract assets

1,781

 

(10,530)

 

 

(8,749)

(15,666)

 

3,064

 

(2,791)

 

(15,393)

Inventories

(32,595)

 

5,907

 

14,723

 

(11,965)

(207,300)

 

88

 

(6,066)

 

(213,278)

Prepaid expenses and other assets

(27,657)

 

 

 

(27,657)

(2,939)

 

 

 

(2,939)

Accounts payable

101,265

 

 

(11,900)

 

89,365

234,525

 

 

6,066

 

240,591

Accrued liabilities

20,985

 

25

 

(2,823)

 

18,187

68,452

 

(47)

 

2,475

 

70,880

Cash provided by operating activities

$

37,224

 

$

 

$

 

$

37,224

$

68,300

 

$

 

$

 

$

68,300